Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings
Earlier continuous administration of mepolizumab could be useful in controlling relapse and refractory disease of EGPA. The administration can reduce the need for less desirable treatment protocols such as long‐term corticosteroids.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-08-01
|
| Series: | Journal of Cutaneous Immunology and Allergy |
| Online Access: | https://doi.org/10.1002/cia2.12295 |
| _version_ | 1827160891781545984 |
|---|---|
| author | Takaharu Ikeda Toshiro Komatsu Kae Yokoyama Tamihiro Kawakami |
| author_facet | Takaharu Ikeda Toshiro Komatsu Kae Yokoyama Tamihiro Kawakami |
| author_sort | Takaharu Ikeda |
| collection | DOAJ |
| description | Earlier continuous administration of mepolizumab could be useful in controlling relapse and refractory disease of EGPA. The administration can reduce the need for less desirable treatment protocols such as long‐term corticosteroids. |
| first_indexed | 2024-03-08T06:35:25Z |
| format | Article |
| id | doaj.art-7b1de8ade8e94ba18bb3418741cc3971 |
| institution | Directory Open Access Journal |
| issn | 2574-4593 |
| language | English |
| last_indexed | 2025-03-21T00:20:14Z |
| publishDate | 2023-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Journal of Cutaneous Immunology and Allergy |
| spelling | doaj.art-7b1de8ade8e94ba18bb3418741cc39712024-08-03T08:45:41ZengFrontiers Media S.A.Journal of Cutaneous Immunology and Allergy2574-45932023-08-016413213310.1002/cia2.12295Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findingsTakaharu Ikeda0Toshiro Komatsu1Kae Yokoyama2Tamihiro Kawakami3Division of Dermatology Tohoku Medical and Pharmaceutical University Sendai JapanDivision of Dermatology Tohoku Medical and Pharmaceutical University Sendai JapanDivision of Dermatology Tohoku Medical and Pharmaceutical University Sendai JapanDivision of Dermatology Tohoku Medical and Pharmaceutical University Sendai JapanEarlier continuous administration of mepolizumab could be useful in controlling relapse and refractory disease of EGPA. The administration can reduce the need for less desirable treatment protocols such as long‐term corticosteroids.https://doi.org/10.1002/cia2.12295 |
| spellingShingle | Takaharu Ikeda Toshiro Komatsu Kae Yokoyama Tamihiro Kawakami Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings Journal of Cutaneous Immunology and Allergy |
| title | Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings |
| title_full | Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings |
| title_fullStr | Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings |
| title_full_unstemmed | Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings |
| title_short | Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings |
| title_sort | earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings |
| url | https://doi.org/10.1002/cia2.12295 |
| work_keys_str_mv | AT takaharuikeda earliercontinuousadministrationofmepolizumabforeosinophilicgranulomatosiswithpolyangiitisbasedoncutaneousfindings AT toshirokomatsu earliercontinuousadministrationofmepolizumabforeosinophilicgranulomatosiswithpolyangiitisbasedoncutaneousfindings AT kaeyokoyama earliercontinuousadministrationofmepolizumabforeosinophilicgranulomatosiswithpolyangiitisbasedoncutaneousfindings AT tamihirokawakami earliercontinuousadministrationofmepolizumabforeosinophilicgranulomatosiswithpolyangiitisbasedoncutaneousfindings |